Industry & Business

Diaceutics Raises €4.3 Million to Support Global Expansion

 Breaking News
  • 90 New Jobs at E + I Engineering in Donegal The Taoiseach, Leo Varadkar TD, has announced 90 new jobs at E+I Engineering Ltd in Donegal. E+I Engineering Ltd is a global leader in the critical power distribution sector, manufacturing electrical switchgear, busduct systems and energy management software, for some of the most recognisable brands and technically advanced companies all over the world. Announcing the jobs boost, [...]...
  • €8 Million in Government Funding Awarded by SEAI to Innovative Energy Research Projects The Government has announced €8 million in funding to support 45 innovative energy projects in companies and research institutions across Ireland. The Sustainable Energy Authority of Ireland (SEAI) is responsible for awarding the funding to the 45 projects which aim to develop solutions that will help our homes, businesses and communities deliver a cleaner energy future. [...]...
  • McKeever Hotel Group Renovates Dunadry Hotel in Multi-million Pound Investment McKeever Hotel Group, one of Northern Ireland’s largest family hotel groups, is undertaking a multi-million pound investment designed to revitalise the Dunadry Hotel to a four star, luxury business and leisure venue. The acquisition of the Dunadry Hotel last year was the 5th property to be added to the McKeever Hotel Group portfolio which,  also purchased [...]...
  • Resilient Performance by Breedon Group Breedon Group, a leading construction materials group in the UK and Ireland, has reported revenue of £378.4 million for the six months to 30 June 2018, up from £326.3 million in the corresponding period of 2017. Underlying earnings before interest and tax (EBIT) increased by 17% to £42.0 million. However, excluding acquisitions, both revenue and [...]...
  • 250 New Jobs Announced by Alchemy in Major Investment in Northern Ireland Alchemy Technology Services has announced it is setting up a European Centre of Excellence in Londonderry. It will provide software implementation and technology consultancy to the UK and European insurance sector. The company will provide certified staff to System Integrators, Software Providers and insurance companies for the implementation of digital solutions across the insurance industry. To [...]...

Diaceutics Raises €4.3 Million to Support Global Expansion

Diaceutics Raises €4.3 Million to Support Global Expansion
April 09
11:53 2018

Irish company, Diaceutics, the diagnostic commercialisation company that improves patient outcomes via better diagnostic testing, has raised €4.3 million in new mezzanine financing from two partners, WhiteRock Capital Partners and Silicon Valley Bank. The money will be used to support the organisation’s continued global expansion.

Specifically, Diaceutics will use the funding to invest in the data analytics services that it provides to pharmaceutical clients and continue to expand its global laboratory network. The company will also look to grow the internal team of experts to deliver data-driven insights designed to improve diagnostic testing that benefits patients.

A recent analysis of Diaceutics testing data revealed that, globally, over 150,000 cancer patients are missing out on potentially life-saving therapies due to substandard diagnostic testing. By investing in expanding their data sources, and continuing to build expertise in oncology and general medicine disease areas, Diaceutics will further enable pharmaceutical clients to more effectively commercialise targeted medications. The results will deliver enhanced diagnostics and more effective treatment for patients.

Over the last three years, the company has experienced revenue growth of 60% year-on-year. In 2017, it achieved revenue of $10 million and aims to reach $40 million revenue by the end of 2020. Moreover, the organisation currently works with 31 out of the world’s top 35 pharmaceutical companies. It recently, announced a partnership with Intel and Lenovo to leverage artificial intelligence in a machine learning environment to further improve the diagnosis and treatment of patients.

By working with WhiteRock Capital Partners, which works with businesses with export potential, and Silicon Valley Bank, which enables companies across the areas of technology, healthcare and data to access emerging markets across the globe, Diaceutics will continue its accelerated growth path and increase its international reach.

Speaking about the new partnerships, Peter Keeling, CEO, Diaceutics, said: “Our focus has always been, and will continue to be, helping patients benefit from better testing. Silicon Valley Bank and WhiteRock Capital Partners have been hugely supportive of this vision and we are delighted to have them as partners at the table.

“We need to continually broaden our global data capabilities and insights; this mezzanine financing allows us to keep pace with our data collection and protection infrastructure while expanding globally. Furthermore, we are eager to continue diversifying beyond our expertise in oncology into general medicine areas, and provide our pharmaceutical clients with invaluable insights that help them ensure patients who can benefit from these precision drugs are indeed receiving them.”

Andrew Gowdy, Senior Portfolio Manager, WhiteRock Capital Partners, commented: “Diaceutics is paving the way when it comes to precision medicine, transforming how patients are diagnosed and treated. Partnering with a company that is revolutionising healthcare and expanding at an incredible rate is very exciting.”

These sentiments were echoed by Clive Lennox, Director of Irish Business Development, Silicon Valley Bank, who said: “Our aim is to work with innovators who are solving real world problems and Diaceutics certainly delivers those solutions. We’re committed to supporting the burgeoning Irish technology market and we are thrilled to be involved with such a dynamic organisation, as it takes the next step in its journey and expands out into a wider range of markets.”

CAPTION:

Pictured at the announcement are (L-R): Andrew Gowdy, Senior Portfolio Manager, WhiteRock Capital Partners; Peter Keeling, CEO, Diaceutics; and Clive Lennox, Director of Irish Business Development, Silicon Valley Bank. Mandatory Credit ©Press Eye/Darren Kidd

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4